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Abstract
Background: One of the best sources for high quality information about healthcare interventions is a systematic
review. A well-conducted systematic review includes a comprehensive literature search. There is limited empiric
evidence to guide the extent of searching, in particular the number of electronic databases that should be searched.
We conducted a cross-sectional quantitative analysis to examine the potential impact of selective database searching
on results of meta-analyses.
Methods: Our sample included systematic reviews (SRs) with at least one meta-analysis from three Cochrane Review
Groups: Acute Respiratory Infections (ARI), Infectious Diseases (ID), Developmental Psychosocial and Learning Problems
(DPLP) (n = 129). Outcomes included: 1) proportion of relevant studies indexed in each of 10 databases; and 2) changes
in results and statistical significance of primary meta-analysis for studies identified in Medline only and in Medline plus
each of the other databases.
Results: Due to variation across topics, we present results by group (ARI n = 57, ID n = 38, DPLP n = 34). For ARI,
identification of relevant studies was highest for Medline (85 %) and Embase (80 %). Restricting meta-analyses to trials
that appeared in Medline + Embase yielded fewest changes in statistical significance: 53/55 meta-analyses showed no
change. Point estimates changed in 12 cases; in 7 the change was less than 20 %. For ID, yield was highest for Medline
(92 %), Embase (81 %), and BIOSIS (67 %). Restricting meta-analyses to trials that appeared in Medline + BIOSIS yielded
fewest changes with 1 meta-analysis changing in statistical significance. Point estimates changed in 8 of 31 meta-analyses;
change less than 20 % in all cases. For DPLP, identification of relevant studies was highest for Medline (75 %) and Embase
(62 %). Restricting meta-analyses to trials that appeared in Medline + PsycINFO resulted in only one change in significance.
Point estimates changed for 13 of 33 meta-analyses; less than 20 % in 9 cases.
Conclusions: Majority of relevant studies can be found within a limited number of databases. Results of meta-analyses
based on the majority of studies did not differ in most cases. There were very few cases of changes in statistical significance.
Effect estimates changed in a minority of meta-analyses but in most the change was small. Results did not change in a
systematic manner (i.e., regularly over- or underestimating treatment effects), suggesting that selective searching may not
introduce bias in terms of effect estimates.
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Background
The realization of effective and efficient health care ser-
vices requires that decisions are informed by the best
available evidence. Arguably the best source for such in-
formation is high quality knowledge syntheses, such as
systematic reviews (SRs). One of the hallmarks of a well-
conducted SR is a thorough, objective and reproducible
search of a range of sources to identify as many relevant
studies as possible, to minimize bias and assist in achiev-
ing reliable estimates of effects [1]. Details on the extent
of the search, and in particular the number of electronic
databases that should be searched, however, are not
available. The Cochrane Handbook states that the search
should be as extensive as possible and that the Cochrane
Central Register of Controlled Trials (CENTRAL),
Medline and Embase are the most important sources to
search for studies for inclusion in Cochrane reviews [1].
Methodological standards for the conduct of new
Cochrane interventions require searches of CENTRAL,
Medline and Embase, and reviewers are encouraged to
consider subject specific databases (e.g. CINAHL for
nursing related topics, or PsycINFO for psychological in-
terventions) and regional databases (e.g. LILACS) [2].
Guidance on the contributions of international, national,
regional and/or subject specific databases, however, is
not specific. Standards for SRs from the Institute of
Medicine acknowledge that “little empirical evidence is
available to guide the development of an SR biblio-
graphic search strategy” ([3], p74). The standards list
several bibliographic databases including CENTRAL, the
Database of Abstracts of Reviews of Effectiveness
(DARE), Embase, Medline, as well as two regional data-
bases from Africa and the Caribbean; however, the rec-
ommendations are not explicit about which and how
many databases must be searched.
Much of the empirical evidence that exists for ques-
tions of searching involves examining the sensitivity and
precision of different databases and search filters in
terms of study identification [4–22]. One important gap
is the modest amount of empirical evidence demonstrat-
ing the impact on results and conclusions from different
approaches to searching. In 2003, Sampson et al. pub-
lished a paper investigating the impact of including trials
indexed only in Embase on the effect estimate of a
meta-analysis [23]. Among 968 randomized controlled
trials from 61 meta-analyses, 10 % were found in
Embase but not Medline. In 24 meta-analyses, including
Embase-unique trials decreased interventions effects by
8 %. The authors recommended further investigation in
recognition of ongoing changes to bibliographic data-
bases. In an analysis of 44 systematic reviews on diabetes
interventions, it was shown that basing a meta-analysis
only on the results of a Medline search would miss trials
that could affect the result 34 % of the time [24]. In
2015, Halladay et al. investigated the impact of using
sources beyond PubMed (Medline) in systematic re-
views. The authors randomly selected 50 Cochrane
Reviews that searched PubMed and Embase and in-
cluded a meta-analysis of ≥10 studies. They examined if
excluding the studies not found in PubMed affected
results, and found that meta-analysis using only
PubMed-indexed versus all available studies led to a dif-
ferent conclusion in only a single case [25].
The evidence-base on database selection for systematic
reviews is limited to showing the impact of searching
Medline only, or excluding Embase. To our knowledge,
the contribution of a range of databases or the combin-
ation of different database selections on the results of
meta-analysis has not been reported. Further, advances
over recent years, including the increased scope of
Medline and Embase, and allied health databases (e.g.,
CINAHL, PsycINFO), registration of clinical studies, and
the increasing reliance on web-based searching to locate
grey literature, raise questions about indicators of com-
prehensive literature searches. While methodological
guidance for SRs encourages comprehensive searching,
there are diminishing returns with each additional data-
base searched [7] and the impact of searching each add-
itional database in terms of the final results and
conclusions is not known. Moreover, more serendipitous
discovery methods (e.g., cited reference searching) may
yield more relevant studies than more database search-
ing [6, 10, 13, 19]. In practice, reasonable limits must be
placed on the number of sources to be searched, and
currently these limits are determined in the absence of
any broad agreement around stopping rules for search-
ing. The objective of this study was to examine the po-
tential impact on the results of existing SRs if searching
was restricted to select bibliographic databases.
Methods
Sample
The sample was derived from a register of SRs that we
maintain as part of our mandate with Cochrane Child
Health. The register includes approximately 1,400 SRs
relevant to child health that are published in the
Cochrane Database of Systematic Reviews (CDSR). The
CDSR was chosen for this analysis as Cochrane reviews:
1) provide tabulated data from the component trials
allowing for re-analysis; 2) provide a detailed list of ref-
erences for all relevant trials; and, 3) have been reported
to be of higher methodological quality [26, 27], which
may translate into more comprehensive searches, hence
more ability to examine our hypothesis around extent of
searching and impact on results and conclusions. As
part of earlier work, we extracted information from each
of the SRs including detailed information on the search
strategy (e.g., databases searched) and the data used
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from the individual studies for the primary analysis [28].
The register has been updated on a regular basis as part
of the ongoing research within Cochrane Child Health.
For this project, we included all reviews containing at least
one meta-analysis from the three review groups contribut-
ing the most reviews: Acute Respiratory Infections
(ARI; n = 57), Infectious Diseases (ID; n = 38), and
Development, Psychosocial and Learning Problems
(DPLP; n = 34). We included reviews regardless of the
nature of the outcome, i.e., we included meta-analyses
of dichotomous and continuous outcomes.
Analysis
To determine our set of databases for investigation we
sampled 50 reviews conducted by three Cochrane review
groups (ARI, DPLP and Airways) and developed a
preliminary list of 108 information sources. From the
preliminary list, we excluded meta-search databases (e.g.
SciSearch), citation databases (e.g. Scopus, Web of
Science), trial registry databases (e.g. metaRegister of
Controlled Trials), regional subsets of Medline (e.g.
African Index Medicus), dissertation databases (e.g.
Australasian Digital Theses Program), and highly special-
ized databases (e.g. Bibliography of Nordic Criminology,
European Committee for Homeopathy thesis database).
We excluded citation databases (Scopus, Web of Science)
as the selected studies from our sample set of Cochrane
reviews may have been added to these databases only after
the reviews were completed and as a result of being refer-
enced in them. CENTRAL was also excluded since all in-
cluded trials in published Cochrane reviews are added to
CENTRAL. Including CENTRAL, or any citation data-
bases, would bias our results in favour of these sources,
and we could not assume included studies would have
been located in these sources prior to the publication of
the Cochrane reviews in our sample.
The remaining information sources were reviewed by
our research librarian (RF) and a second author (DMD).
We selected the ten databases as those most likely to be
searched in SRs of healthcare interventions: Ovid Med-
line (1946-Current), BIOSIS Citation Index via Thomson
Reuters Web of Knowledge (1926-Current), CAB Direct
via CABI (1910-Current), CINAHL Plus with Full Text via
EBSCOhost (1937-Current), Ovid Embase (1974-Current),
Ovid ERIC (1965-Current), Ovid HaPI (Health and
Psychosocial Instruments) (1985-Current), Ovid IPA
(International Pharmaceutical Abstracts) (1965-Current),
LILACS via BIREME Virtual health Library (inception-
Current), and Ovid PsycINFO (1806-Current). Given the
high overlap between Ovid Medline and the PubMed
interface via NCBI Entrez, and the frequent use of Ovid
Medline for Cochrane reviews, we selected the Ovid inter-
face for searching studies included in Medline. Similarly,
we selected Ovid Embase over Embase.com, in this case
as only the Ovid version of the database was available at
our center.
We then listed all of the studies included in the primary
meta-analysis for each SR (i.e., our reference standard).
We chose the meta-analysis that was designated as the
primary outcome by the authors or, if not specified, we se-
lected the first meta-analysis presented in the review. We
assumed the first meta-analysis presented would be one of
the more important outcomes. This also typically con-
tained the most studies, providing more data to run our
analyses. Our analysis involved five key components:
1) For each meta-analysis, we searched the ten
databases listed above to determine the number of
trials contained in each. We calculated the mean
percentage of trials per meta-analysis contained in
each database, as well as the minimum, first quartile,
median, third quartile, and maximum.
2) We recorded how many of the studies not indexed
in Medline were indexed in each of the additional
databases. For the DPLP reviews, we found a
relatively lower proportion of studies indexed in
Medline and larger proportion in PsycINFO;
therefore, we based our analyses on studies found
(or not found) in Medline and/or PsycINFO.
3) For each meta-analysis, we re-analyzed the data
based on studies that were identified only in Medline
and Medline plus each of the additional databases
(e.g., Medline + BIOSIS, Medline + Embase, etc.). For
DPLP reviews we conducted this analysis for
Medline + PsycINFO and then Medline + PsycINFO
along with each additional database. For dichotomous
outcomes, we calculated the mean of the ratios of
point estimates for Medline and Medline + additional
database relative to the original meta-analysis (i.e.,
reference standard). We calculated the mean
confidence interval widths on the log scale of the
ratios of confidence interval widths for Medline and
Medline + additional database relative to the reference
standard. For continuous outcomes, we calculated the
mean of the standardized differences of effect sizes
and mean ratios of confidence interval widths. For all
analyses, we also calculated the minimum, first
quartile, median, third quartile, and maximum
ratios. When computing ratios of point estimates
and confidence intervals, we ignored the direction
of effect and considered only the magnitude; that
is to say for each meta-analysis, if the ratio was
less than 1, we replaced it with its reciprocal.
Thus the minimum value of any ratio was 1. In this
way we would see the magnitude of the differences
rather than allowing over- and under-estimates to
potentially cancel each other by giving us a mean ratio
that was close to 1.
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4) We recorded the number of times the statistical
significance of the result changed and categorized
changes as: reference standard significant and
Medline or Medline plus additional database not
significant, or reference standard not significant and
Medline or Medline plus additional database significant.
5) Finally, we examined in more detail the meta-analyses
that had changes in effects based on selective database
searching to understand the frequency and extent of
changes, and whether there were patterns relative to
the number of relevant studies and proportion retrieved
through selective searching.
Statistical analyses were conducted using SAS 9.3
(SAS institute Inc., Cary, NC USA). Results are pre-
sented by Review Group (i.e., ARI, ID, DPLP) due to het-
erogeneity in some findings across groups.
Results
Our analyses are based on 57 meta-analyses from ARI,
38 from ID, and 34 from DPLP (See Additional file 1).
The median years of publication for the SRs used in our
analysis were 2012 (ARI), 2008.5 (ID), and 2011 (DPLP).
The median numbers of studies (and participants) in-
cluded in the primary or first meta-analysis were 4
(1,031) for ARI, 3 (553) for ID, and 3 (308 for DPLP).
Table 1 shows the mean percent of trials from the ori-
ginal meta-analyses that were found in each database. For
ARI, a mean of 85 % of trials was identified in Medline
(median 100 %), followed by Embase (80 %, median
100 %), and BIOSIS (65 %, median 67 %). The pattern was
similar for ID, with a mean of 92 % of trials identified in
Medline (median 100 %), followed by Embase (81 %, me-
dian 86 %), and BIOSIS (67 %, median 68 %). Likewise, for
DPLP a mean of 75 % was identified in Medline (median
100 %), followed by Embase (62 %, median 75 %), and
BIOSIS (49 %, median 100 %).
Table 2 shows the databases where trials were found
that were not found in Medline. Eighty-four percent of
all trials contained in ARI meta-analyses (333/398) were
found in Medline. Among the remaining 65 trials, 20
were found in Embase and 13 were found in BIOSIS.
The remaining databases found very few trials that were
not identified in Medline. Eighty-seven percent of all
trials contained in ID meta-analyses (206/238) were
found in Medline. Among the remaining 32 trials, 7
were found in BIOSIS and 6 were found in Embase; the
remaining databases only contained 0 or 1 each. Due to
the relatively lower proportion of trials found in Medline
alone for DPLP, we combined Medline and PsycINFO
which together contained 84 % of trials (121/144). Of
the remaining 23, 4 were found in ERIC, 2 in Embase
and 1 in BIOSIS; the remaining databases contained 0.
In terms of the impact on the statistical significance of
results (Table 3), Medline + Embase yielded the fewest
changes for ARI with 53 of the 55 meta-analyses show-
ing no change, while one meta-analysis changed from
significant to non-significant and one meta-analysis
changed from non-significant to significant. For ID,
Medline + BIOSIS yielded the fewest changes with only 1
meta-analysis changing from significant to non-significant.
All other analyses (Medline alone and Medline + each














Acute Respiratory Infections (n = 57)
Medline 85 0 79 100 100 100
BIOSIS 65 0 50 67 100 100
CAB Direct 0.3 0 0 0 0 20
CINAHL 22 0 0 0 33 100
EMBASE 80 0 75 100 100 100
ERIC 0.2 0 0 0 0 13
HAPI 0 0 0 0 0 0
IPA 23 0 0 20 42 100
LILACS 0 0 0 0 0 0
PsycINFO 2 0 0 0 0 88
Infectious Diseases (n = 38)
Medline 92 33 86 100 100 100
BIOSIS 67 0 50 68 100 100
CAB Direct 5 0 0 0 0 100
CINAHL 10 0 0 0 17 50
EMBASE 81 20 67 86 100 100
ERIC 0 0 0 0 0 0
HAPI 0 0 0 0 0 0
IPA 17 0 0 1 29 100
LILACS 5 0 0 0 0 100
PsycINFO 3 0 0 0 0 100
Developmental Psychosocial Learning Problems (n = 34)
Medline 75 0 50 100 100 100
BIOSIS 49 0 0 50 88 100
CAB Direct 0 0 0 0 0 0
CINAHL 34 0 0 35 50 100
EMBASE 62 0 25 75 100 100
ERIC 26 0 0 0 50 100
HAPI 0 0 0 0 0 0
IPA 7 0 0 0 0 67
LILACS 3 0 0 0 0 100
PsycINFO 47 0 0 50 90 100
aPercentages do not match those in Table 2; the percentages here are an average
across meta-analyses
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additional database) resulted in only 2 changes (one in each
direction). For DPLP, all combinations (Medline +
PsycINFO and Medline + PsycINFO+ additional database)
resulted in only one change (significant to non-significant).
We calculated the mean of the ratios and confidence
interval widths for point estimates of Medline alone and
Medline + each database relative to the reference stand-
ard for dichotomous outcomes. For ARI and ID, the
lowest mean ratios were found for Medline + BIOSIS
(1.03 ARI, 1.02 ID) and Medline + Embase (1.05 ARI,
1.02 ID), although the ratios were low in all cases. The
ratios of the confidence interval widths were consistent
with the ratios of the point estimate. For DPLP, all ratios
were the same at 1.04 for Medline + PsycINFO and
Medline + PsycINFO with each additional database. We
conducted similar analyses based on standardized differ-
ences of effect sizes for continuous outcomes. The mean
of the standardized differences of point estimates was
0.01 for ARI reviews for all analyses except one
(Medline + IPA) and the mean of the ratios of confidence
interval widths differed little across cases, ranging from
1.15 to 1.17. For ID, the mean of the standardized differ-
ences of point estimates showed little variation, ranging
from 0.0004 to 0.0006, with the mean of the ratios of
confidence interval widths ranging from 1.26 to 1.28.
For DPLP, the mean of the standardized differences of
Table 2 Databases where trials were found that were not found in Medlinea
Acute Respiratory Infections
(n = 57 meta-analyses)




Number found that were
not in MedLine (of 65)
Total Trials
Found (of 238)b
Number found that were
not in MedLine (of 32)
Total Trials
Found (of 144)b
Number found that were not in
MedLine or PsycINFO (of 23)
Medline 333 (84 %) - 206 (87 %) - - -
BIOSIS 258 13 164 7 72 1
CAB Direct 1 0 4 0 0 0
CINAHL 75 0 32 1 43 0
EMBASE 310 20 178 6 84 2
ERIC 1 1 0 0 32 4
HAPI 0 0 0 0 0 0
IPA 104 3 40 1 13 0
LILACS 0 0 5 0 2 0
PsycINFO 8 3 2 0 121 (84 %)c -
aPercentages do not match those in Table 1; the percentages here are an average across all trials (by review group)
bNumber of trials not found in any database was 26 for ARI, 18 for ID, and 12 for DPLP. Number of systematic reviews with ≥1 trial not found in any database was
10 for ARI, 9 for ID, and 8 for DPLP
cTotal trials found in Medline and/or PsycINFO
Table 3 Impact of selective searching on statistical significance of results
Acute Respiratory Infections (n = 55) Infectious Diseases (n = 37) Developmental, Psychosocial and Learning























Medline (alone) 4 2 49 1 1 35 - - -
BIOSIS 3 2 50 0 1 36 1 0 32
CAB Direct 4 2 49 1 1 35 1 0 32
CINAHL 4 2 49 1 1 35 1 0 32
EMBASE 1 1 53 1 1 35 1 0 32
ERIC 3 2 50 1 1 35 1 0 32
HAPI 4 2 49 1 1 35 1 0 32
IPA 4 2 49 1 1 35 1 0 32
LILACS 4 2 49 1 1 35 1 0 32
PsycINFO 3 2 50 1 1 35 1 0 32
aeach database in addition to Medline
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point estimates was 0.01 for all comparisons except
Medline + PsycINFO + ERIC which was 0.004. The mean
of the ratios of the confidence interval widths ranged
from 1.09 to 1.11. Detailed results from these analyses
are available in the Appendix.
We examined the specific meta-analyses in more detail
to contextualize the above results. For ARI, the results of
only 17 of the 57 meta-analyses changed when restricting
included studies to those found in Medline + BIOSIS (12
of 57 for Medline + Embase; Table 4). Therefore, the above
results demonstrating changes to point estimates and
confidence intervals are driven by a minority of the meta-
analyses and cannot necessarily be generalized (or aver-
aged) to any specific meta-analysis. Among the 17 meta-a-
nalyses, the proportion of relevant studies identified by
Medline + BIOSIS ranged from 0 to 93 % (median 66 %).
Typically when a low proportion was identified, the ori-
ginal meta-analyses had included relatively few studies
(i.e., in all cases where less than 50 % of relevant studies
were found in Medline + BIOSIS, the original meta-
analysis had 6 or fewer studies). The point estimate chan-
ged less than 20 % in most cases (n = 12 of 17). In two
cases no studies were found in Medline + BIOSIS; in both
cases the original meta-analysis only included 2 studies
and both involved complementary medicine interven-
tions for influenza (i.e., homeopathic oscillococcinum
and Chinese medicinal herbs).[29, 30] The 12 meta-
analyses that changed when restricting studies to
those found in Medline + Embase were a subset of the
17 analyzed for Medline + BIOSIS and followed the
same patterns (see Table 4).
For ID, the results of only 9 of 31 meta-analyses chan-
ged when restricting included studies to those found in
Medline + Embase (8 of 31 for Medline + BIOSIS;
Table 5). Among the 9 meta-analyses, the proportion of
relevant studies identified by Medline + Embase ranged
from 60 to 86 % (median 75 %). As for ARI, when a
lower proportion was identified, the original meta-
analyses had included relatively few studies. The point
estimate changed less than 20 % in all cases and less
Table 4 Impact of selective searching on results of meta-analyses from acute respiratory infections





Effect size Lower CI Upper CI Number
of trials




Medline + BIOSIS (changes in 17 of 57 meta-analyses)
1a MD 5 −21.29 −29.59 −13 1 −22.9 −41.34 −4.46 20 7.0
2a MD 35 −1.24 −1.54 −0.94 26 −1.42 −1.77 −1.06 74 12.7
3a MD 24 −0.45 −0.96 0.05 19 −0.25 −0.9 0.39 79 44.7
4a RD 2 −0.13 −0.21 −0.05 1 −0.16 −0.26 −0.05 50 18.8
5a RD 3 −0.05 −0.12 0.02 1 −0.04 −0.14 0.06 33 20.0
6 MH OR 6 0.27 0.15 0.50 3 0.19 0.08 0.46 50 29.6
7a, b MH OR 7 0.35 0.12 1.01 6 0.26 0.12 0.6 86 25.7
8a RR 2 0.48 0.17 1.34 0 - - - 0 -
9a, b SMD 8 0.49 0.16 0.81 6 0.51 0.1 0.93 75 3.9
10 MD 3 0.5 0.10 0.90 2 0.43 −0.01 0.87 67 14.0
11 RR 6 0.67 0.50 0.89 5 0.75 0.55 1.04 83 10.7
12 RR 25 0.9 0.80 1.01 22 0.91 0.8 1.02 88 1.1
13a RR 6 0.95 0.59 1.51 3 0.96 0.82 1.11 50 1.0
14a, b RR 29 0.95 0.92 0.98 19 0.96 0.94 0.99 66 1.0
15a, b RR 15 1.09 0.64 1.85 13 0.9 0.54 1.49 87 17.4
16a RR 2 1.32 0.87 2.00 0 - - - 0 -
17 RR 15 1.82 0.98 3.38 14 1.97 1.06 3.64 93 7.6
Medline + Embase (changes in 12 of 57 meta-analyses; data below show cases where results were different from Medline + BIOSIS results aboveb)
7 MH OR 7 0.35 0.12 1.01 4 0.14 0.04 0.53 57 60.0
9 SMD 8 0.49 0.16 0.81 6 0.4 0.07 0.73 75 18.4
14 RR 29 0.95 0.92 0.98 19 0.97 0.94 1 66 2.1
15 RR 15 1.09 0.64 1.85 14 0.96 0.58 1.57 93 11.9
acases where results also changed for Medline + Embase; bcases where results were different between Medline + BIOSIS and Medline + Embase analyses
CI confidence interval, MD mean difference, MH OR Mantel Haenszel odds ratio, RD risk difference, RR risk ratio, SMD standardized mean difference
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than 10 % in 7 of 9 cases. The 8 meta-analyses that
changed when restricting studies to those found in Med-
line + BIOSIS were a subset of the 9 analyzed for
Medline + Embase and are presented in Table 5.
For DPLP, there were 15 of 33 meta-analyses that
changed when restricting included studies to those
found in Medline + PsycInfo (13 of 33 for Medline +
PsycInfo + ERIC; Table 6). Among the 15 meta-analyses,
the proportion of relevant studies identified in Medline
+ PsycInfo ranged from 0 to 94 % (median 75 %). As for
ARI and ID, when a lower proportion was identified, the
original meta-analyses had included relatively few stud-
ies. For example, in the case where there were no studies
found in Medline + PsycInfo, the original meta-analysis
only had 2 studies and was on a topic not traditionally
considered as a healthcare intervention (i.e., restorative
justice conferencing for reducing recidivism in young of-
fenders) [31]. In two cases the original meta-analyses
had 2 included studies and Medline + PsycInfo only
identified 1 (50 %); topics were music therapy for autism
spectrum disorder and financial benefits for child health
and well-being in low income or socially disadvantaged
families in developed world countries [32, 33]. The point
estimate changed less than 20 % in 13 cases. Data for
Medline + PsycInfo + ERIC are presented in Table 6.
Discussion
Systematic reviews are critical for informed, evidence-
based decision-making. They have been described as the
cornerstone of knowledge translation and are the foun-
dation for key knowledge tools such as clinical practice
guidelines and patient decision aids [34]. One of the fun-
damental components and initial steps in conducting a
SR is the literature search. Best practices recommend ex-
tensive searching to ensure comprehensive identification
of all studies relevant to the question of interest and to
avoid bias in results and conclusions. However, extensive
searching contributes substantially to the workload, re-
sources, and time required to complete a SR. Moreover,
there is limited empiric evidence upon which to base the
extent of searching or the potential impact of selective
searching on the results of SRs.
This study provides much needed empiric evidence
to support prioritizing particular databases to search
in SRs. Our results show that the vast majority of
relevant studies appear within a limited number of
databases. Further, the results of meta-analyses based
on the majority of studies (that appear within a lim-
ited number of databases) do not differ in the major-
ity of cases. In particular, there were very few cases
of results changing in statistical significance. The ef-
fect estimates changed in a minority of meta-analyses
but in the majority of these they changed to a small
extent. Finally, results do not appear to change in a
systematic manner (i.e., regularly over- or underesti-
mating treatment effects), suggesting that searching
select databases may not introduce bias in terms of
effect estimates.
Table 5 Impact of selective searching on results of meta-analysis from infectious diseases





Effect size Lower CI Upper CI Number
of trials




Medline + Embase (changes in 9 of 31 meta-analyses)
1a, b MD 35 −24.76 −33.61 −15.91 30 −22.22 −31.85 −12.6 86 10.3
2a, b RR 5 0.41 0.11 1.64 3 NE - - 60 -
3 RR 4 0.48 0.35 0.65 3 0.57 0.29 1.09 75 15.8
4a, b RR 21 0.53 0.49 0.57 16 0.51 0.46 0.56 76 3.8
5a, b MH OR 11 0.59 0.45 0.79 7 0.61 0.41 0.89 64 3.3
6a RR 3 0.62 0.19 2.04 2 0.56 0.14 2.14 67 9.7
7a, b MH OR 10 0.68 0.49 0.95 8 0.59 0.41 0.86 80 13.2
8a RR 8 0.71 0.62 0.80 6 0.72 0.64 0.82 75 1.4
9a RR 13 0.99 0.90 1.09 11 0.95 0.86 1.05 85 4.0
Medline + BIOSIS (changes in 8 of 31 meta-analyses; data below show cases where results were different from Medline + Embase results aboveb)
1 MD 35 −24.76 −33.61 −15.91 29 −23.18 −32.94 −13.42 83 6.4
2 RR 5 0.41 0.11 1.64 3 NE - - 60 -
4 RR 21 0.53 0.49 0.57 17 0.49 0.44 0.54 81 7.5
5 MH OR 11 0.59 0.45 0.79 8 0.64 0.48 0.87 73 7.8
7 MH OR 10 0.68 0.49 0.95 8 0.54 0.34 0.86 80 20.6
CI confidence interval, MD mean difference, MH OR Mantel Haenszel odds ratio, NE not estimable (all study groups had zero counts); RR risk ratio
acases where results also changed for Medline + BIOSIS; bcases where results were different between Medline + BIOSIS and Medline + Embase analyses
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While our results suggest that the majority of relevant
studies appear in a limited number of databases, the
choice of databases is topic-specific. We purposefully se-
lected three different clinical areas to examine our hypoth-
esis. For two of the clinical areas (acute respiratory
infections and infectious diseases), we found the highest
yield from Medline + Embase or Medline + BIOSIS. Fur-
ther, these combinations resulted in the least impact on ef-
fect estimates and fewest changes in statistical significance
of results. For the third area (Developmental, Psychosocial
and Learning Problems), Medline + PsycInfo yielded the
most relevant studies, with ERIC contributing more add-
itional studies than other databases including Embase or
BIOSIS. Further research in these and other topic areas is
needed to provide empiric evidence to inform searching
and optimize the time and resources that are required to
produce SRs. In cases where we found a very low propor-
tion of studies in select databases, the original meta-
analyses included few studies and topics were often
outside of mainstream healthcare interventions (e.g., com-
plementary and alternative medicine, financial benefits, re-
storative justice). Further, our results are based on SRs
that focused on randomized trials; these results may not
be generalizable to other study designs or types of data.
For those conducting SRs, it may be appropriate to
limit the number of databases being searched for main-
stream healthcare interventions. If reviewers anticipate a
small number of studies (based on preliminary searches
conducted as part of developing the SR protocol and the
complete search strategy), they may choose to search a
larger number of databases at the outset; if they find a
small number of studies having searched few databases,
they may choose to search more (e.g., an iterative ap-
proach), or supplement with other sources such as those
suggested for identification of grey literature (e.g., con-
tent experts, relevant websites, conferences, etc.). Our
results may be particularly pertinent in the context of
rapid reviews. There has been increased attention re-
cently to methods for rapid reviews in the interests of
producing knowledge syntheses more quickly and effi-
ciently to inform end-users’ decision-making needs [35–
37]. Searching is one dimension of SRs that is typically
altered to streamline processes and produce reviews
more quickly [37, 38]. Alterations include limiting the
number of databases and extent of grey literature
searching, and placing restrictions on date, setting,
language and study design. Further, end-users of SRs
have indicated that extent of literature searching is
Table 6 Impact of selective searching on results of meta-analysis from developmental, psychosocial and learning problems





Effect size Lower CI Upper CI Number
of trials




Medline + PsycInfo (changes in 15 of 33 meta-analyses)
1a, b MD 5 −1.25 −4.56 2.06 3 −1.48 −5.96 3 60 15.5
2a SMD 10 −0.24 −0.35 −0.13 8 −0.25 −0.38 −0.11 80 4.0
3a MD 5 0.02 −0.09 0.12 4 0 −0.11 0.11 80 NA
4 SMD 10 0.47 0.06 0.88 9 0.49 0.04 0.93 90 4.1
5a SMD 2 0.5 0.22 0.79 1 0.48 0.18 0.77 50 4.0
6a RR 10 0.51 0.37 0.72 8 0.48 0.34 0.69 80 5.9
7a MH OR 4 0.61 0.27 1.39 3 0.48 0.14 1.6 75 21.3
8a RR 6 0.69 0.60 0.78 5 0.66 0.59 0.74 83 4.3
9a, b RR 10 0.73 0.56 0.95 7 0.65 0.47 0.9 70 11.0
10a RR 17 0.76 0.69 0.83 16 0.75 0.68 0.82 94 1.3
11a MH OR 4 0.87 0.61 1.25 3 0.78 0.52 1.17 75 10.3
12a Other 2 1 0.59 1.71 0 - - - 0 -
13a, b MH OR 2 1.05 0.90 1.23 1 1.09 0.85 1.41 50 3.7
14a MH OR 7 1.68 1.20 2.36 2 1.78 0.93 3.41 29 5.6
15 MD 4 14.37 12.30 16.44 3 12.33 10.14 14.51 75 14.2
Medline + PsycInfo + ERIC (changes in 13 of 33 meta-analyses; data below show cases where results were different from Medline + PsycInfo results aboveb)
1 MD 5 −1.25 −4.56 2.06 4 −0.96 −5.07 3.15 0.8 23.2
9 RR 10 0.73 0.56 0.95 9 0.69 0.52 0.92 0.9 5.5
13 MH OR 2 1.05 0.90 1.23 2 1.09 0.91 1.31 1 3.7
CI confidence interval, MD mean difference, MH OR Mantel Haenszel odds ratio, NA not applicable, RR risk ratio, SMD standardized mean difference
acases where results also changed for Medline + PsycInfo + ERIC; bcases where results were different between Medline + PsycInfo and Medline + PsycInfo + ERIC
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one of the most acceptable trade-offs to increase re-
view efficiencies [39].
Our study had several limitations. First, we focused
on a sample of SRs published in the Cochrane Data-
base of Systematic Reviews. These were from three
clinical areas and focused on healthcare interventions.
Results may not be generalizable outside of these
clinical areas, for non-conventional interventions, or
for SRs examining other types of research questions
(e.g., diagnostic, prognostic). Second, our sample was
based on SRs that had already been completed; we
used the original search strategies and the studies that
they yielded as our reference standard. There may
have been variability in the comprehensiveness of the
original search strategies; however, Cochrane reviews
are recognized as high quality (including criterion re-
lated to searching) and typically search specialized
registers that include studies identified through exten-
sive searching activities including hand-searching.
Third, we did not evaluate the searches per se, rather
we looked to see whether the included studies could
be found in each database. Therefore, our results are
based on whether the studies were present in the da-
tabases but do not reflect the ability of searchers (or
a given search strategy) to find those references. Fur-
ther, since our study was retrospective, some of the
studies may have been deposited into the databases
after the original search was run; therefore, our re-
sults may overestimate the identification of studies
that are published and indexed closer to the time that
the search is implemented. Fourth, we focused on
analyses on the primary (or first listed) outcome from
each review. Results may vary across outcomes; how-
ever, our focus on the primary outcome provided the
most data with which to examine our hypotheses.
Fifth, to avoid biasing our results in favor of sources
which included studies referenced in our sample set
of Cochrane reviews, we were not able to evaluate
the relative contributions from searching CENTRAL
and citation databases (Web of Science and Scopus).
Sixth, we did not include the PubMed interface via
NCBI Entrez for Medline or Embase.com for Embase
(https://www.nlm.nih.gov/pubs/factsheets/dif_med_-
pub.html). There may be studies located in PubMed
or Embase.com that may not have been found in
Ovid Medline or Ovid Embase [40]. Finally, we only
examined the impact of Medline and Medline plus
one other database. Further research examining the
contributions of different numbers of databases,
ranked according to their potential for identifying
relevant studies in a specific topic area, may be
beneficial.
This study confirms previous methods studies demon-
strating that the majority of SR trials are found in
Medline [7, 25], and that Embase is more likely than
other databases to find additional relevant trials not
retrieved by Medline [23, 24]. Our study contributes
evidence to support the addition of subject-specific
database (PsycINFO, ERIC) for specific topics, and
the contribution of Biosis in addition to Embase for
clinical medicine topics. While this study provides im-
portant information, future research in this area is
needed to help guide searching in SRs, and to quan-
tify the impact of different approaches to searching
on the results and conclusions of reviews. As men-
tioned above, our results reflect the presence of stud-
ies in the different databases but do not reflect the
ability of searches to identify those studies. Research
evaluating selective searching in a prospective manner
and in different topic areas would be beneficial.
Moreover, additional empiric research will help pro-
vide more solid evidence upon which to base recom-
mendations for searching in the future.
Conclusions
This study provides quantitative data regarding the po-
tential impact on meta-analysis results of restricting
searches to select databases. The vast majority of rele-
vant studies appear within a limited number of data-
bases. The results of meta-analyses based on the
majority of studies (which appear within a limited num-
ber of databases) did not differ in most cases; specific-
ally, there were very few cases of results changing in
statistical significance. Effect estimates changed in a mi-
nority of meta-analyses but in most the change was
small. Results did not change in a systematic manner
(i.e., regularly over- or underestimating treatment ef-
fects), suggesting that selective searching may not intro-
duce bias in terms of effect estimates. This information
may be useful to increase efficiencies in the conduct of
SRs and in developing methods guidance for rapid re-
views. Future research across different topics will provide
additional evidence upon which to base recommendations
for searching in evidence reviews.
Appendix
Detailed results data
This file includes four tables with the following data:
1) mean of the ratios of point estimate of Medline/data-
base estimate to reference standard point estimate for
dichotomous outcomes, 2) mean (on the log scale) of
the ratios of confidence interval widths of Medline/data-
base estimate to reference standard point estimate for
dichotomous outcomes, 3) mean of standardized differ-
ences of effect sizes for continuous outcomes, 4) mean
of the ratios of confidence interval widths of Medline/
database estimate to reference standard point estimate
for dichotomous outcomes.
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Table 7 Mean of the ratios of point estimate of Medline/database
estimate to reference standard point estimate for dichotomous
outcomes
Database Mean Minimum Q1 Median Q3 Maximum
Acute Respiratory Infections (n = 37)
Medline (alone) 1.06 1.00 1.00 1.00 1.00 2.5
BIOSIS 1.03 1.00 1.00 1.00 1.00 1.4
CAB Direct 1.06 1.00 1.00 1.00 1.00 2.5
CINAHL 1.06 1.00 1.00 1.00 1.00 2.5
EMBASE 1.05 1.00 1.00 1.00 1.00 2.5
ERIC 1.06 1.00 1.00 1.00 1.00 2.5
HAPI 1.06 1.00 1.00 1.00 1.00 2.5
IPA 1.07 1.00 1.00 1.00 1.00 2.5
LILACS 1.06 1.00 1.00 1.00 1.00 2.5
PsycINFO 1.06 1.00 1.00 1.00 1.00 2.5
Infectious Diseases (n = 31)
Medline (alone) 1.06 1.00 1.00 1.00 1.00 2.14
BIOSIS 1.02 1.00 1.00 1.00 1.00 1.26
CAB Direct 1.06 1.00 1.00 1.00 1.00 2.14
CINAHL 1.06 1.00 1.00 1.00 1.00 2.14
EMBASE 1.02 1.00 1.00 1.00 1.00 1.19
ERIC 1.06 1.00 1.00 1.00 1.00 2.14
HAPI 1.06 1.00 1.00 1.00 1.00 2.14
IPA 1.05 1.00 1.00 1.00 1.00 2.14
LILACS 1.06 1.00 1.00 1.00 1.00 2.14
PsycINFO 1.06 1.00 1.00 1.00 1.00 2.14
Developmental, Psychosocial and Learning Problems (n = 16)
Medline/PsychINFO
(alone)
1.04 1.00 1.00 1.01 1.06 1.27
BIOSIS 1.04 1.00 1.00 1.00 1.06 1.27
CAB Direct 1.04 1.00 1.00 1.01 1.06 1.27
CINAHL 1.04 1.00 1.00 1.01 1.06 1.27
EMBASE 1.04 1.00 1.00 1.00 1.06 1.27
ERIC 1.04 1.00 1.00 1.01 1.06 1.27
HAPI 1.04 1.00 1.00 1.01 1.06 1.27
IPA 1.04 1.00 1.00 1.01 1.06 1.27
LILACS 1.04 1.00 1.00 1.01 1.06 1.27
Table 8 Mean (on the log scale) of the ratios of confidence interval
widths of Medline/database estimate to reference standard point
estimate for dichotomous outcomes
Database Mean Minimum Q1 Median Q3 Maximum
Acute Respiratory Infections (n = 37)
Medline (alone) 1.12 1.00 1.00 1.00 1.00 3.17
BIOSIS 1.11 1.00 1.00 1.00 1.00 3.17
CAB Direct 1.12 1.00 1.00 1.00 1.00 3.17
CINAHL 1.12 1.00 1.00 1.00 1.00 3.17
EMBASE 1.09 1.00 1.00 1.00 1.00 3.17
ERIC 1.12 1.00 1.00 1.00 1.00 3.17
HAPI 1.12 1.00 1.00 1.00 1.00 3.17
IPA 1.11 1.00 1.00 1.00 1.00 3.17
LILACS 1.12 1.00 1.00 1.00 1.00 3.17
PsycINFO 1.12 1.00 1.00 1.00 1.00 3.17
Infectious Diseases (n = 31)
Medline (alone) 1.10 1.00 1.00 1.00 1.00 2.67
BIOSIS 1.02 1.00 1.00 1.00 1.00 1.25
CAB Direct 1.10 1.00 1.00 1.00 1.00 2.67
CINAHL 1.10 1.00 1.00 1.00 1.00 2.67
EMBASE 1.08 1.00 1.00 1.00 1.00 2.67
ERIC 1.10 1.00 1.00 1.00 1.00 2.67
HAPI 1.10 1.00 1.00 1.00 1.00 2.67
IPA 1.09 1.00 1.00 1.00 1.00 2.67
LILACS 1.10 1.00 1.00 1.00 1.00 2.67
PsycINFO 1.10 1.00 1.00 1.00 1.00 2.67
Developmental, Psychosocial and Learning Problems (n = 16)
Medline/PsychINFO
(alone)
1.16 1.00 1.00 1.00 1.20 2.14
BIOSIS 1.16 1.00 1.00 1.00 1.20 2.14
CAB Direct 1.16 1.00 1.00 1.00 1.20 2.14
CINAHL 1.16 1.00 1.00 1.00 1.20 2.14
EMBASE 1.16 1.00 1.00 1.00 1.20 2.14
ERIC 1.13 1.00 1.00 1.00 1.20 2.14
HAPI 1.16 1.00 1.00 1.00 1.20 2.14
IPA 1.16 1.00 1.00 1.00 1.20 2.14
LILACS 1.16 1.00 1.00 1.00 1.20 2.14
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Table 9 Mean of standardized differences of effect sizes for
continuous outcomes
Database Mean Minimum Q1 Median Q3 Maximum
Acute Respiratory Infections (n = 19)
Medline (alone) 0.01 0 0 0 0.03 0.12
BIOSIS 0.01 0 0 0 0.03 0.04
CAB Direct 0.01 0 0 0 0.03 0.12
CINAHL 0.01 0 0 0 0.03 0.12
EMBASE 0.01 0 0 0 0.03 0.9
ERIC 0.01 0 0 0 0.02 0.04
HAPI 0.01 0 0 0 0.03 0.12
IPA 0.02 0 0 0 0.03 0.12
LILACS 0.01 0 0 0 0.03 0.12
PsycINFO 0.01 0 0 0 0.02 0.04
Infectious Diseases (n = 6)
Medline (alone) 0.0006 0.00 0.00 0.00 0.00 0.003
BIOSIS 0.0004 0.00 0.00 0.00 0.00 0.003
CAB Direct 0.0006 0.00 0.00 0.00 0.00 0.003
CINAHL 0.0005 0.00 0.00 0.00 0.00 0.003
EMBASE 0.0007 0.00 0.00 0.00 0.00 0.004
ERIC 0.0006 0.00 0.00 0.00 0.00 0.003
HAPI 0.0006 0.00 0.00 0.00 0.00 0.003
IPA 0.0006 0.00 0.00 0.00 0.00 0.003
LILACS 0.0006 0.00 0.00 0.00 0.00 0.003
PsycINFO 0.0006 0.00 0.00 0.00 0.00 0.003
Developmental, Psychosocial and Learning Problems (n = 19)
Medline/PsychINFO
(alone)
0.01 0.00 0.00 0.00 0.02 0.08
BIOSIS 0.01 0.00 0.00 0.00 0.02 0.08
CAB Direct 0.01 0.00 0.00 0.00 0.02 0.08
CINAHL 0.01 0.00 0.00 0.00 0.02 0.08
EMBASE 0.01 0.00 0.00 0.00 0.02 0.08
ERIC 0.004 0.00 0.00 0.00 0.00 0.02
HAPI 0.01 0.00 0.00 0.00 0.02 0.08
IPA 0.01 0.00 0.00 0.00 0.02 0.08
LILACS 0.01 0.00 0.00 0.00 0.02 0.08
Table 10 Mean of the ratios of confidence interval widths of
Medline/database estimate to reference standard point estimate
for dichotomous outcomes
Database Mean Minimum Q1 Median Q3 Maximum
Acute Respiratory Infections (n = 19)
Medline (alone) 1.17 1.00 1.00 1.00 1.28 2.22
BIOSIS 1.17 1.00 1.00 1.00 1.28 2.22
CAB Direct 1.17 1.00 1.00 1.00 1.28 2.22
CINAHL 1.17 1.00 1.00 1.00 1.28 2.22
EMBASE 1.15 1.00 1.00 1.00 1.28 2.22
ERIC 1.18 1.00 1.00 1.00 1.28 2.22
HAPI 1.17 1.00 1.00 1.00 1.28 2.22
IPA 1.17 1.00 1.00 1.00 1.28 2.22
LILACS 1.17 1.00 1.00 1.00 1.28 2.22
PsycINFO 1.16 1.00 1.00 1.00 1.28 2.22
Infectious Diseases (n = 6)
Medline (alone) 1.27 1.00 1.00 1.00 1.17 2.46
BIOSIS 1.28 1.00 1.00 1.00 1.17 2.54
CAB Direct 1.27 1.00 1.00 1.00 1.17 2.46
CINAHL 1.27 1.00 1.00 1.00 1.17 2.48
EMBASE 1.26 1.00 1.00 1.00 1.00 2.57
ERIC 1.27 1.00 1.00 1.00 1.17 2.46
HAPI 1.27 1.00 1.00 1.00 1.17 2.46
IPA 1.27 1.00 1.00 1.00 1.17 2.46
LILACS 1.27 1.00 1.00 1.00 1.17 2.46
PsycINFO 1.27 1.00 1.00 1.00 1.17 2.46
Developmental, Psychosocial and Learning Problems (n = 19)
Medline/PsychINFO
(alone)
1.11 1.00 1.00 1.00 1.06 2.15
BIOSIS 1.11 1.00 1.00 1.00 1.06 2.15
CAB Direct 1.11 1.00 1.00 1.00 1.06 2.15
CINAHL 1.11 1.00 1.00 1.00 1.06 2.15
EMBASE 1.10 1.00 1.00 1.00 1.06 2.15
ERIC 1.09 1.00 1.00 1.00 1.04 2.15
HAPI 1.11 1.00 1.00 1.00 1.06 2.15
IPA 1.11 1.00 1.00 1.00 1.06 2.15
LILACS 1.11 1.00 1.00 1.00 1.06 2.15
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Additional file
Additional file 1: Description and citations of included systematic reviews.
This file includes a description of the included systematic reviews, and the
citations for all systematic reviews included in the analysis (57 from Acute
Respiratory Infections, 38 from Infectious Diseases, 34 from Developmental
Psychosocial Learning Problems). (DOCX 47 kb)
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